Alta-innovations news

NewsRss FeedAtom Feed

University of Birmingham Spinout Company is developing a novel drug for the treatment of Glaucoma

Description
Scientists at the University of Birmingham have received funding from the Technology Strategy Board, the UK's innovation agency, to develop a novel multi action siRNA drug with proven neuroprotective and neuroregenerative activity to treat Glaucoma.
Date:
20/03/2013

PsiOxus Therapeutics Completes Patient Enrollment for Phase II Wasting Disease Therapeutic MT-102

Description
PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, has completed patient enrollment for its Phase II clinical trial to study MT-102, a small molecule therapeutic for the treatment of cancer cachexia.
Date:
04/03/2013

Serascience Ltd shortlisted for Medilink UK Healthcare Business Awards 2013

Description
Having been awarded best start-up at the 2012 Medilink West Midlands Healthcare Business Awards in December, the list of acalades for Serascience could continue to grow following the recent announcement that the company has now been shortlisted for the Medilink UK Awards.
Date:
22/02/2013

Celebrating 60 years of fuel cell and hydrogen research

Description
To celebrate an international reputation in fuel cell and hydrogen research, the University of Birmingham recently hosted a seminar to invited guests both from industry and academia showcasing pioneering projects that will continue to help shape a sustainable future.
Date:
25/01/2013

High Voltage DC Control Published Patent

Description
Workers at the University of Birmingham have developed a voltage source converter VSC for HVDC.
Date:
24/01/2013
Displaying 21 to 30 of 53
Previous 1 2 3 4 5 Next